Ludwig Institute For Cancer Research
- Assets
- $25.8m
- Revenue
- $89.3m
- Investments
- $5.5m
- Employees
- 91
- Location
- New York, NY
- Founding
- 08/1971
- Data as of
- 12/2021
- EIN
- 23-7121131
Organization Overview
Ludwig Institute For Cancer Research is located in New York, NY. The organization was established in 1971. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. As of 12/2021, Ludwig Institute For Cancer Research employed 91 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Ludwig Institute For Cancer Research is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Ludwig Institute For Cancer Research generated $89.3m in total revenue. The organization has seen a slow decline revenue. Over the past 7 years, revenues have fallen by an average of (1.0%) each year. All expenses for the organization totaled $90.0m during the year ending 12/2021. As we would expect to see with falling revenues, expenses have declined by (0.9%) per year over the past 7 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
THE LUDWIG INSTITUTE FOR CANCER RESEARCH LTD IS A GLOBAL NON-PROFIT INSTITUTE COMMITTED TO IMPROVING THE UNDER- STANDING & CONTROL OF CANCER THROUGH LABORATORY AND CLINICAL RESEARCH.
Describe the Organization's Program Activity:
Part 3 - Line 4a
LABORATORY RESEARCH LEADING TO CLINICAL APPLICATIONS - SEE SCHEDULE O
CLINICAL RESEARCH - SEE SCHEDULE O
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Dr Chi Van Dang Director, Scientific Director | OfficerTrustee | 50 | $939,103 |
Dr Jonathan Skipper Exec Vice-Pres Tech Develop. | Officer | 45 | $717,110 |
Dr Don Cleveland Group Leader | 45 | $675,948 | |
Dr Richard Kolodner Group Leader | 55 | $546,080 | |
Dr Ralph Venhaus Chief Medical Officer | 50 | $500,432 | |
Dr Bing Ren Group Leader | 45 | $470,258 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
University Of Lausanne Research Services | 12/30/21 | $13,300,588 |
University Of Oxford Research Services | 12/30/21 | $8,722,848 |
Milbank Llp Legal Services | 12/30/21 | $6,485,617 |
De Duve Institute Research Services | 12/30/21 | $3,094,422 |
Princeton University Research Services | 12/30/21 | $5,100,000 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $45,000,000 |
| Government grants | $4,704,322 |
| All other contributions, gifts, grants, and similar amounts not included above | $11,244,086 |
| Noncash contributions included in lines 1a–1f | $1,834,220 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $60,948,408 |
| Total Program Service Revenue | $0 |
| Investment income | $277,032 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $2,480,060 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $22,498,726 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $89,264,708 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $3,352,127 |
| Compensation of current officers, directors, key employees. | $2,084,880 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $16,328,237 |
| Pension plan accruals and contributions | $1,304,205 |
| Other employee benefits | $2,748,950 |
| Payroll taxes | $1,368,644 |
| Fees for services: Management | $3,032,997 |
| Fees for services: Legal | $7,584,895 |
| Fees for services: Accounting | $282,140 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $1,653,325 |
| Advertising and promotion | $0 |
| Office expenses | $459,803 |
| Information technology | $717,806 |
| Royalties | $276,848 |
| Occupancy | $3,760,188 |
| Travel | $45,240 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $34,642 |
| Interest | $891 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $337,328 |
| All other expenses | $748,795 |
| Total functional expenses | $90,029,244 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $8,920,477 |
| Savings and temporary cash investments | $302,627 |
| Pledges and grants receivable | $1,448,901 |
| Accounts receivable, net | $20,817 |
| Loans from Officers, Directors, or Controlling Persons | $22,000 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $525,954 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $2,231,092 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $5,549,662 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $6,789,855 |
| Total assets | $25,811,385 |
| Accounts payable and accrued expenses | $9,901,109 |
| Grants payable | $0 |
| Deferred revenue | $6,634,901 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $5,376,612 |
| Total liabilities | $21,912,622 |
| Net assets without donor restrictions | $0 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $59,542 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $3,839,221 |
| Total liabilities and net assets/fund balances | $25,811,385 |
Grants Recieved
Over the last fiscal year, we have identified 3 grants that Ludwig Institute For Cancer Research has recieved totaling $345,833.
| Awarding Organization | Amount |
|---|---|
Muscular Dystrophy Association Chicago, IL PURPOSE: RESEARCH | $145,833 |
Amyotrophic Lateral Sclerosis Assn Arlington, VA PURPOSE: DRUG DEVELOPMENT CONTRACT | $125,000 |
Amyotrophic Lateral Sclerosis Assn Arlington, VA PURPOSE: POST DOCTORAL FELLOWSHIP | $75,000 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Dana Farber Mass General Brigham Cancer Care Inc Boston, MA | $42,647,489 | $95,186,368 |
Ludwig Institute For Cancer Research New York, NY | $25,811,385 | $89,264,708 |
Institute For Cancer Research Philadelphia, PA | $148,137,241 | $82,576,402 |
Wistar Institute Of Anatomy & Biology Philadelphia, PA | $414,460,000 | $115,831,000 |
American Association For Cancer Research Philadelphia, PA | $261,131,206 | $103,171,549 |
Nsabp Foundation Inc Pittsburgh, PA | $90,333,934 | $55,869,172 |
Cancer Research Institute Inc New York, NY | $130,438,312 | $33,675,150 |
Centre County Cancer Center State College, PA | $6,772,389 | $27,589,392 |
Nrg Oncology Foundation Inc Philadelphia, PA | $13,392,636 | $27,206,954 |
Lake Champlain Cancer Research Org Inc Essex Jct, VT | $0 | $292,033 |
Addgene Inc Watertown, MA | $22,116,271 | $23,985,910 |
Count Me In Inc Cambridge, MA | $7,331,909 | $8,017,841 |